Metabolic
Renal Diseases
Cardio, renal and metabolic medications: hitting many birds with one stone
Magdi Elsharkawy Egypr
Covid-19 Vaccines and kidney
Gamal Elnaggar Egypr
Post Transplant Diabetes update
Mohammad Ghnaimmat Jordan
Debates and controversies in Nephrology
Dialysis in patients with Hepatorenal Syndrome
Pro: Waleed Masoud Egypt
Dialysis in patients with Hepatorenal Syndrome
Cons: Mahmoud Emara Egypt
Can gadolinium be Used Safely for Imaging in Stage 4/5 CKD Patients?
Pro:Hala El-Wakel Egypt
Can NSAIDs be Used Safely for Analgesia in Patients with CKD?
Pro: Tarek Tantawy Egypt
Can NSAIDs be Used Safely for Analgesia in Patients with CKD?
Cons: Amir El-Okali Egypt
Is Rituximab Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy?
Pro:Mona Roushdy Egypt
Is Rituximab Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy?
Cons:Eman Sarhan Egypt
ESNT
members blossom internationally
Hany Hafez
President Elect, AFRAN
Chair, Hemodialysis, AFRAN
Dina Abdellatif
Treasure, IFKF
Rasha Darwish
Treasure, AFRAN
Mohamed Abdel Gawad
Co-chair, Wed & Media, AFRAN
Academic
& Research Kit
Common ethical violation of scientific writing and publishing
Ahmed Shokeir
Egypt
Consenting children and vulnerable adults
Ahmed Halawa
UK
Challenges and obstacles in kidney donation in Arab world
Faisal Shaheen
KSA
Comparative outcome of deceased donor kidney transplant from donors with SARS-Cov-2RNA detection: A single center study
Mohamed Magdy
USA
A blueprint for expanding live kidney donation
Hassan Ibrahim
USA
Risk and complications of living kidney donation
Ehab Wafa
Egypt
Recently approved therapeutic agents in nephrology
Hussein Elfishawy
Egypt
Glomerular diseases in the kidney allograft with a particular focus on de novo disease
Ibrahim Batal
USA
Changing landscape of Tubulointerstitial nephritis
Mohamed Atta
USA
Maher Saad
Egypt
Ahmed ElKeraie
Egypt
Think amyloidosis Al amyloidosis overview
Ahmed Elkeraie
Egypt
Think amyloidosis Al amyloidosis management
Mohamed Abdelkader Mourad
Egypt